Modern European monographs for quality control of Chinese herbs

Planta Medica

Volumn 76, Issue 17, 2010, Pages 2004-2011

  Bauer, Rudolf ^a   Franz, Gerhard ^b  

^a TCM Research Center   (Austria)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

herbal medicinal products; monographs; pharmacopoeia; quality control; TCM; traditional Chinese medicine

Indexed keywords

ANGELICA EXTRACT; ANGELICA SINENSIS EXTRACT; ASTRAGALUS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; BUPLEURUM ROOT EXTRACT; CARTHAMUS EXTRACT; CHINESE DRUG; CITRUS FRUIT EXTRACT; ECLIPTA PROSTRATA EXTRACT; EPHEDRA EXTRACT; EUCOMMIA EXTRACT; EUCOMMIA ULMOIDES EXTRACT; EVODIA FRUIT EXTRACT; FORSYTHIA EXTRACT; GARDENIA EXTRACT; GASTRODIA EXTRACT; HERBACEOUS AGENT; LIGUSTICUM CHUANXIONG EXTRACT; LYCIUM EXTRACT; MAGNOLIA OFFICINALIS EXTRACT; PAEONIA RADIX; PAEONIA SUFFRUTICOSA EXTRACT; PINELLIA EXTRACT; PLATYCODON GRANDIFLORUM EXTRACT; PORIA COCOS EXTRACT; PUERARIA EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; STEPHANIA TETRANDRA EXTRACT; UNINDEXED DRUG;

CHINESE MEDICINE; DRUG IDENTIFICATION; DRUG PURITY; DRUG QUALITY; DRUG SAFETY; EUROPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL LITERATURE; NONHUMAN; REVIEW;

DRUGS, CHINESE HERBAL; EUROPEAN UNION; MEDICINE, CHINESE TRADITIONAL; PHARMACOPOEIAS AS TOPIC; QUALITY CONTROL;

EID: 78649906826     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250532     Document Type: Review

References (40)

1. Dobos G J., Tan L, Cohen M H., McIntyre M, Bauer R, Li X, Bensoussan A. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country. Compl Ther Med 2005 13 183-190
2. Vlietinck A, Pieters L, Apers S. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Planta Med 2009 75 683-688
3. Artiges A, Spieser J M. The role and future of the European Pharmacopoeia. Regul Affairs J 1994 (MayJune) 349-351 437-440
4. Artiges A. The role of pharmacopoeias in international harmonisation. J Pharm Biomed Anal 2001 24 769-772
5. European Directorate for the Quality of Medicines & Health Care. European pharmacopoeia. Available at. http://online.edqm.eu/entry.htm Accessed November 2, 2010[nl]
6. Xiao P-G. Recent developments on medicinal plants in China. J Ethnopharmacol 1983 7 95-109
7. European Directorate for the Quality of Medicines & Health Care. Technical Guide for The Elaboration of Monographs. Available at. http://www.edqm.eu/medias/fichiers/Technical-Guide-for-the-Elaboration-of- Monographs-on-herbal-drugs-and-herbal-drug-preparations-2007.pdf Accessed November 2, 2010
8. Hsu H Y. A Study of Chinese homonymic medicinal herbs. Oriental Healing Arts Int Bull 1987 12 387-408
9. Hu Y, Jiang Z, Leung K S., Zhao Z. Simultaneous determination of naphthoquinone derivatives in Boraginaceous herbs by high-performance liquid chromatography. Anal Chim Acta 2006 577 26-31
10. Zhao Z Z., Hu Y, Liang Z, Yuen J P., Jiang Z, Leung K S. Authentication is fundamental for standardization of Chinese medicines. Planta Med 2006 72 865-874
11. Wagner H, Bauer R, editors. Chinese drug monographs and analysis. Kötzting Verlag für Ganzheitliche Medizin Dr. Erich Wühr GmbH 19962010
12. Chinese Pharmacopoeia Commission. TLC Atlas of Chinese Crude Drugs in Pharmacopoeia of the People's Republic of China. Beijing People's Medical Publishing House 2009
13. Zhong X K., Li D C., Jiang J G. Identification and quality control of Chinese medicine based on the fingerprint techniques. Curr Med Chem 2009 16 3064-3075
14. Yip P Y., Chau C F., Mak C Y., Kwan H S. DNA methods for identification of Chinese medicinal materials. Chin Med 2007 2 9
15. Carles M, Cheung M K., Moganti S, Dong T T., Tsim K W., Ip N Y., Sucher N J. A DNA microarray for the authentication of toxic traditional Chinese medicinal plants. Planta Med 2005 71 580-584
16. Techen N, Crockett S L., Khan I A., Scheffler B E. Authentication of medicinal plants using molecular biology techniques to compliment conventional methods. Curr Med Chem 2004 11 1391-1401
17. Kabelitz L. Zur mikrobiologischen Qualität von Arznei- und Gewürzdrogen. Sind die bisherigen Anforderungen sachgerecht? Z Arznei Gewürzpfl 2001 6 174-175
18. Kneifel W, Czech E, Kopp B. Microbial contamination of medicinal plants a review. Planta Med 2002 68 5-15
19. Kabelitz L, Sievers H. Contaminants of medicinal and food herbs with a view to EU regulations. Innovations in Food Technol 2004 1 25-27
20. Leung K S. Y., Chan K, Chan C L., Lu G H. Systematic evaluation of organochlorine pesticide residues in Chinese materia medica. Phytother Res 2005 19 514-518
21. Kabelitz L. Heavy metals in herbal drugs. Eur J Herbal Med (Phytotherapy) 1998 4 1-9
22. Chizzola R, Michitsch H, Franz C. Monitoring of metallic micronutrients and heavy metals in herbs, spices and medicinal plants from Austria. Eur Food Res Technol 2003 216 407-411
23. Gasser U, Klier B, Kühn A V., Steinhoff B. Current findings on the heavy metal content in herbal drugs. Pharmeuropa Sci Notes 2009 1 37-49
24. Nortier J L., Vanherweghem J L. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 2002 181182 577-580
25. Ioset J R., Raoelisona G E., Hostettmann K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 2003 41 29-36
26. Heinrich M, Chan J, Wanke S, Neinhuis C, Simmonds M S. Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1and 2-a global assessment based on bibliographic sources. J Ethnopharmacol 2009 125 108-144
27. Fu P P., Yang Y C., Xia Q, Chou M C., Cui Y Y., Lin G. Pyrrolizidine alkaloids tumorigenic components in Chinese herbal medicines and dietary supplements. J Food Drug Anal 2002 10 198-211
28. Roeder E. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 2000 55 711-726
29. Xue P S., Leung A Y. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica. J Chromatogr A 2008 1216 1913-1940
30. Liang Y Z., Xie P S., Chan K. Chromatographic Fingerprinting and Metabolomics for Quality Control of TCM. Comb Chem High Throughput Screen advance online publication 30 September 2010[nl]
31. Liu A H., Lin Y H., Yang M, Guo H, Guan S H., Sun J H., Guo D A. Development of the fingerprints for the quality of the roots of Salvia miltiorrhiza and its related preparations by HPLC-DAD and LC-MS(n). J Chromatogr B Analyt Technol Biomed Life Sci 2007 846 32-41
32. Cao J, Wei Y J., Qi L W., Li P, Qian Z M., Luo H W., Chen J, Zhao J. Determination of fifteen bioactive components in Radix et Rhizoma Salviae Miltiorrhizae by high-performance liquid chromatography with ultraviolet and mass spectrometric detection. Biomed Chromatogr 2008 22 164-172
33. Liu M, Li Y, Chou G, Cheng X, Zhang M, Wang Z. Extraction and ultra-performance liquid chromatography of hydrophilic and lipophilic bioactive components in a Chinese herb Radix Salviae Miltiorrhizae. J Chromatogr A 2007 1157 51-55
34. Csupor D, Wenzig E M., Zupk I, Wölkart K, Hohmann J, Bauer R. Qualitative and quantitative analysis of aconitine-type and lipo-alkaloids of Aconitum carmichaeli roots. J Chromatogr A 2009 1216 2079-2086
35. Singhuber J, Zhu M, Prinz S, Kopp B. Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? J Ethnopharmacol 2009 126 18-30
36. Lu G, Dong Z, Wang Q, Qian G, Huang W, Jiang Z, Leung K S., Zhao Z. Toxicity assessment of nine types of decoction pieces from the daughter root of Aconitum carmichaeli (Fuzi) based on the chemical analysis of their diester diterpenoid alkaloids. Planta Med 2010 76 825-830
37. World Health Organization. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. Geneva World Health Organization Geneva 2003
38. Gao W, Duan H, Huang L, Xiao P G., Peak K Y. Good agricultural practice (GAP) and sustainable resource utilization of Chinese materia medica. J Plant Biotech 2002 4 103-107
39. Siow Y L., Gong Y, Au-Yeung K K. W., Woo C W. H., Choy P C. Emerging issues in traditional Chinese medicine. Can J Physiol Pharmacol 2005 83 321-334
40. Chan K, Leung K S., Zhao S S. Harmonization of monographic standards is needed to ensure the quality of Chinese medicinal materials. Chin Med 2009 4 18